Acorah Software Products - Accounts Production 16.2.850 false true 31 January 2024 1 February 2023 false true No description of principal activity 1 February 2024 31 January 2025 31 January 2025 10017038 Mr Narvinder Nandra iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10017038 2024-01-31 10017038 2025-01-31 10017038 2024-02-01 2025-01-31 10017038 frs-core:CurrentFinancialInstruments 2025-01-31 10017038 frs-bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 10017038 frs-bus:FilletedAccounts 2024-02-01 2025-01-31 10017038 frs-bus:Micro-entities 2024-02-01 2025-01-31 10017038 frs-bus:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 10017038 frs-bus:Director1 2024-02-01 2025-01-31 10017038 2023-01-31 10017038 2024-01-31 10017038 2023-02-01 2024-01-31 10017038 frs-core:CurrentFinancialInstruments 2024-01-31
Registered number: 10017038
Nandra Pharma Ltd
Unaudited Financial Statements
For The Year Ended 31 January 2025
AMCI ASSOCIATES LTD
Balance Sheet
Registered number: 10017038
2025 2024
£ £
Fixed assets 2 2
Current assets 5,254 4,068
Creditors: Amounts Falling Due Within One Year (1,557 ) (3,859 )
NET CURRENT ASSETS 3,697 209
TOTAL ASSETS LESS CURRENT LIABILITIES 3,699 211
NET ASSETS 3,699 211
CAPITAL AND RESERVES 3,699 211

Notes

1. General Information
Nandra Pharma Ltd Registered number 10017038 is a limited by shares company incorporated in England and Wales. The Registered Office is 133 Tame Road, Birmingham, B6 7DG.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
For the year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Narvinder Nandra
Director
24/02/2025